April 13, 2020
Article
Clinical Trial in Progress
The drug successfully demonstrated an ability to reduce mutant huntingtin protein, but the clinical benefits of that effect are yet to be determined.
April 12, 2020
Article
NeuroPathways
Examining the underlying roles of poly adenosine diphosphate-ribose (PARP) play in the neurodegeneration of Parkinson disease.
April 11, 2020
Article
Clinical Insights
The assistant professor of Neurology, Concussion and Headache Medicine divisions, Mayo Clinic, Scottsdale, Arizona discussed the evolving migraine treatment landscape and how they have been incorporated into her practice.
April 10, 2020
Article
Features
Will ethical considerations and lack of consent stand in the way of thoroughly exploring the potential of this nondrug therapy?
April 09, 2020
Article
Features
As the treatment of multiple sclerosis continues to evolve and improve, the proposition of lifetime therapy has come under scrutiny.
April 08, 2020
Article
Clinical Viewpoint
Elizabeth Thiele, MD, PhD, answers a variety of questions on treating tuberous sclerosis, and the landscape of treatments available at this time.
April 07, 2020
Article
Cover Story
Significant advancements in genetics and the implementation of artificial intelligence have begun to carve a new, more personalized path for the diagnosis and treatment of seizure disorders.
April 06, 2020
Article
Features
As a marker of impending neurodegeneration, urgency surrounds efforts to slow or stop the progression of REM sleep behavior disorder.